Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
ENFN Stock | USD 9.94 0.08 0.80% |
About 55% of Enfusion's investor base is interested to short. The analysis of the overall prospects from investing in Enfusion suggests that many traders are, at the present time, impartial. Enfusion's investing sentiment overview a quick insight into current market opportunities from investing in Enfusion. Many technical investors use Enfusion stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Enfusion |
Enfusion, Inc. , a leading provider of software-as-a-service solutions for investment managers, announced today the ap
Read at businesswire.com
Enfusion Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Enfusion can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Enfusion Fundamental Analysis
We analyze Enfusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enfusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Enfusion is currently under evaluation in target price category among its peers.
Enfusion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enfusion stock to make a market-neutral strategy. Peer analysis of Enfusion could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics with similar companies.
Peers
Enfusion Related Equities
BRZE | Braze | 2.32 | ||||
MLNK | Meridianlink | 1.88 | ||||
FRSH | Freshworks | 1.01 | ||||
LAW | CS Disco | 0.68 | ||||
ONTF | ON24 | 0.46 | ||||
BLKB | Blackbaud | 0.34 | ||||
PYCR | Paycor HCM | 0.39 | ||||
CWAN | Clearwater Analytics | 0.42 | ||||
PRO | PROS Holdings | 0.43 | ||||
ETWO | E2open Parent | 0.98 |
Check out Enfusion Hype Analysis, Enfusion Correlation and Enfusion Performance. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share 2.155 | Quarterly Revenue Growth 0.154 | Return On Assets 0.0592 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.